Nuvectis Pharma Stock Probability of Future Stock Price Finishing Over 30.48
| NVCT Stock | USD 5.41 0.27 5.25% |
Nuvectis |
Nuvectis Pharma Target Price Odds to finish over 30.48
The tendency of Nuvectis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 30.48 or more in 90 days |
| 5.41 | 90 days | 30.48 | close to zero percent |
Based on a normal probability distribution, the odds of Nuvectis Pharma to move over $ 30.48 or more in 90 days from now is close to zero percent (This Nuvectis Pharma probability density function shows the probability of Nuvectis Stock to fall within a particular range of prices over 90 days) . Probability of Nuvectis Pharma price to stay between its current price of $ 5.41 and $ 30.48 at the end of the 90-day period is about 69.36 .
Given the investment horizon of 90 days Nuvectis Pharma has a beta of -1.43. This indicates as returns on its benchmark rise, returns on holding Nuvectis Pharma are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Nuvectis Pharma is expected to outperform its benchmark. Additionally Nuvectis Pharma has an alpha of 0.2072, implying that it can generate a 0.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Nuvectis Pharma Price Density |
| Price |
Predictive Modules for Nuvectis Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nuvectis Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nuvectis Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nuvectis Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nuvectis Pharma is not an exception. The market had few large corrections towards the Nuvectis Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nuvectis Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nuvectis Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | -1.43 | |
σ | Overall volatility | 1.68 | |
Ir | Information ratio | 0.02 |
Nuvectis Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nuvectis Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nuvectis Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nuvectis Pharma had very high historical volatility over the last 90 days | |
| Nuvectis Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (22.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nuvectis Pharma currently holds about 13.57 M in cash with (15.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93. | |
| Nuvectis Pharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 52.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Mosseri Marlio Charles of 32121 shares of Nuvectis Pharma at 4.64 subject to Rule 16b-3 |
Nuvectis Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nuvectis Stock often depends not only on the future outlook of the current and potential Nuvectis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nuvectis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.6 M | |
| Cash And Short Term Investments | 19.1 M |
Nuvectis Pharma Technical Analysis
Nuvectis Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Nuvectis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nuvectis Pharma. In general, you should focus on analyzing Nuvectis Stock price patterns and their correlations with different microeconomic environments and drivers.